Maravai LifeSciences Holdings, Inc. announced the appointment of Bernd Brust as Chief Executive Officer (CEO) and a member of the Board of Directors, effective June 9, 2025. Mr. Brust succeeds William “Trey” Martin III in these critical leadership roles.
Mr. Brust brings a strong track record of leading diverse, global life sciences organizations, including his previous roles as Executive Chairman and CEO of Antylia Scientific, and CEO of Qualicaps. He also held senior leadership positions at Life Technologies and Invitrogen Corporation.
This leadership transition reflects Maravai’s commitment to accelerating innovation, execution, and financial performance. Mr. Brust’s customer-centric approach and background in transforming scientific organizations align with Maravai’s mission to advance scientific discovery and innovation.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.